ReviewBMJ (Clinical research ed.)2008
Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.
Review in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.BMJ (Clinical research ed.) · 2010Pooled it
- Targeted case finding in the prevention of cardiovascular disease: a stepped wedge cluster randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2016 · on this mapTrial
- Trial
- Evaluating Statin Knowledge-Perceptions and Receptivity Following a Comprehensive Lifestyle Modification Program.American journal of lifestyle medicine · 2026Article
- A study of the relationship between brachial artery vasodilation and platelet/lymphocyte ratio in diabetic patients with coronary atherosclerosis.Journal of clinical laboratory analysis · 2023Article
- Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review.Diagnostics (Basel, Switzerland) · 2022Review
- Cross-sectional analysis of educational inequalities in primary prevention statin use in UK Biobank.Heart (British Cardiac Society) · 2022Article
- The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study.Journal of general internal medicine · 2021Observational
- Multiclass machine learning vs. conventional calculators for stroke/CVD risk assessment using carotid plaque predictors with coronary angiography scores as gold standard: a 500 participants study.The international journal of cardiovascular imaging · 2021Article
- Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.The lancet. Diabetes & endocrinology · 2017Article
- PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.PloS one · 2017Article
- Esophageal cancer: The latest on chemoprevention and state of the art therapies.Pharmacological research · 2016Review
- Big Data and Health Economics: Strengths, Weaknesses, Opportunities and Threats.PharmacoEconomics · 2016Review
- Estimation of 10-Year Risk of Coronary Heart Disease in Nepalese Patients with Type 2 Diabetes: Framingham Versus United Kingdom Prospective Diabetes Study.North American journal of medical sciences · 2015Article
- Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland.Diabetologia · 2015Article
- Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?World journal of gastroenterology · 2014Review
- Screening strategies for cardiovascular disease in asymptomatic adults.Primary care · 2014Review
- Assessment of cardiovascular disease risk in South asian populations.International journal of vascular medicine · 2013Review
- C-reactive protein, fibrinogen, and cardiovascular disease prediction.The New England journal of medicine · 2012Article
- Cardiovascular risk.British journal of clinical pharmacology · 2012Review
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.